WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001089561) AIDS VACCINES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/089561    International Application No.:    PCT/JP2001/004258
Publication Date: 29.11.2001 International Filing Date: 22.05.2001
Chapter 2 Demand Filed:    30.10.2001    
IPC:
A61K 47/30 (2006.01), A61K 47/42 (2006.01)
Applicants: BABA, Masanori [JP/JP]; (JP).
AKASHI, Mitsuru [JP/JP]; (JP).
JAPAN IMMUNORESEARCH LABORATORIES CO., LTD. [JP/JP]; 351-1, NISHIYOKOTE-CHO TAKASAKI-SHI, Gunma 370-0021 (JP) (For All Designated States Except US).
ADACHI, Masakazu [JP/JP]; (JP) (For US Only)
Inventors: BABA, Masanori; (JP).
AKASHI, Mitsuru; (JP).
ADACHI, Masakazu; (JP)
Agent: ARUGA, Mitsuyuki; Kyodo Bldg. 3-6, Nihonbashiningyocho 1-chome Chuo-ku Tokyo 103-0013 (JP)
Priority Data:
2000-151487 23.05.2000 JP
Title (EN) AIDS VACCINES
(FR) VACCINS CONTRE LE SIDA
Abstract: front page image
(EN)AIDS vaccines comprising a microgranular carrier made of a hydrophobic base having lectin bonded thereto and microgranules capturing HIV, or a protein or a peptide which is a part of HIV. Because of being capable of inducing an HIV-specific IgA antibody and having an excellent activity of neutralizing HIV, these vaccines make it possible to prevent HIV-infection and, in its turn, prevent AIDS when transmucosally administered.
(FR)L'invention concerne des vaccins contre le SIDA comprenant un support microgranulaire à base hydrophobe sur laquelle est fixée de la lectine et des microgranules qui capturent le VIH, ou une protéine ou un peptide faisant partie du VIH. De par leur capacité à induire des anticorps IgA spécifiques au VIH et leur excellente capacité de neutralisation du VIH, ces vaccins permettent d'empêcher l'infection par le VIH et par la même l'apparition du SIDA lorsqu'ils sont administrés par voie transmuqueuse.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)